Literature DB >> 6978290

Participation of complement in host defense against encapsulated Haemophilus influenzae types a, c, and d.

C J Corrall, J A Winkelstein, E R Moxon.   

Abstract

Each of the serotypes of Haemophilus influenzae (types a to f) may colonize the respiratory tract of humans, but only type b strains commonly cause invasive systemic infections. To investigate the role of complement in immunity to encapsulated non-type b strains, rats were depleted of C3 with cobra venom factor and challenged with representative serotypes of H. influenzae (type a, b, c, or d) by different routes. After intravenous challenge, rats depleted of C3 had a greater incidence and magnitude of bacteremia with each of the serotypes when compared with normal controls. Intraperitoneal inoculation of type b organisms resulted in meningitis in normal and C3-depleted rats, but only C3-depleted, and not normal, rats developed meningitis after inoculation of serotype a, c, or d. In contrast to systemic inoculation, intranasal challenge with the different serotypes resulted in bloodstream invasion and meningitis only after challenge with type b organisms. These data suggest that complement plays a significant role in immunity to encapsulated, non-type b H. influenzae through its effect on bloodstream clearance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978290      PMCID: PMC351113          DOI: 10.1128/iai.35.3.759-763.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Participation of complement in the nonimmune host defense against experimental Haemophilus influenzae type b septicemia and meningitis.

Authors:  F J Crosson; J A Winkelstein; E R Moxon
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

2.  Incidence and type distribution of capsulated H. influenzae strains.

Authors:  B DAWSON; K ZINNEMANN
Journal:  Br Med J       Date:  1952-04-05

3.  Activation of the alternative complement pathway by Haemophilus influenzae type B.

Authors:  P H Quinn; F J Crosson; J A Winkelstein; E R Moxon
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

4.  Haemophilus influenzae meningitis in infant rats after intranasal inoculation.

Authors:  E R Moxon; A L Smith; D R Averill; D H Smith
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

5.  The third component of the guinea pig complement system. II. Kinetic study of the reaction of EAC'4,2a with guinea pig C'3. Enzymatic nature of C'3 comsumption, multiphasic character of fixation, and hemolytic titration of C'3.

Authors:  H S Shin; M M Mayer
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

6.  Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age-dependent inflammatory responses in cerebrospinal fluid.

Authors:  E R Moxon; P T Ostrow
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

7.  Meningitis due to Haemophilus influenzae other than type b: case report and review.

Authors:  G R Greene
Journal:  Pediatrics       Date:  1978-12       Impact factor: 7.124

8.  The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants.

Authors:  E R Moxon; K A Vaughn
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

9.  Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation.

Authors:  A L Smith; D H Smith; D R Averill; J Marino; E R Moxon
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

  9 in total
  11 in total

Review 1.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

2.  Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.

Authors:  L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

3.  Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease.

Authors:  S M Loosmore; Y P Yang; D C Coleman; J M Shortreed; D M England; M H Klein
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.

Authors:  G B Toews; S Viroslav; D A Hart; E J Hansen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

5.  Participation of complement in host defense against capsule-deficient Haemophilus influenzae.

Authors:  A Zwahlen; J A Winkelstein; E R Moxon
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Occult bacteremia with nontypeable Haemophilus influenzae.

Authors:  L G Rubin; K Staiman; N Kamani
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

8.  Antigenic and phenotypic variations of Haemophilus influenzae type b lipopolysaccharide and their relationship to virulence.

Authors:  A Kimura; E J Hansen
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

9.  Pathophysiology of hemolysis in infections with Hemophilus influenzae type b.

Authors:  S B Shurin; P Anderson; J Zollinger; R K Rathbun
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

Review 10.  Experimental meningitis in the rat: Haemophilus influenzae.

Authors:  A L Smith; M D Greenfield; R D Toothaker
Journal:  Infection       Date:  1984       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.